Evidence-Based Recommendations for Monitoring and Antagonism of Neuromuscular Blockade: Overview of New Guidelines
|
ACPE Activity Number: 0204-0000-24-401-H01-P |
Activity Overview
In this interprofessional activity, expert faculty will discuss the recently released practice guidelines on monitoring and antagonism of neuromuscular blockade and use patient cases to develop an evidence-based approach for the management of neuromuscular monitoring during anesthesia and antagonism of neuromuscular blocking agents prior to extubation. Strategies to improve interprofessional collaboration in emergency situations to ensure that appropriate neuromuscular blockade use, monitoring, and reversal will also be shared.
*Please note, this activity was presented live as a live webinar on 2/21/24. You can only claim credit once for this activity; live or home study
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
This activity was planned to meet the educational needs of pharmacists, physicians, physician assistants, and nurse practitioners who care for patients in the perioperative setting. The pharmacist target audience also includes those who have a clinical, administrative, and/or patient safety focus in the perioperative setting.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Interpret recently released practice guidelines on monitoring and antagonism of neuromuscular blockade.
- Develop an evidence-based approach for the management of neuromuscular monitoring during anesthesia and antagonism of neuromuscular blocking agents prior to extubation.
- Apply strategies to improve interprofessional collaboration in emergency situations to ensure that appropriate neuromuscular blockade use, monitoring, and reversal are followed.
Faculty
Rachel C. Wolfe, PharmD, MHA, BCCCP, Activity Chair
Perioperative Clinical Pharmacy Specialist & Supervisor
Barnes-Jewish Hospital
St. Louis, Missouri
Dr. Wolfe is Clinical Pharmacy Specialist of Perioperative and Surgical Critical Care at Barnes-Jewish Hospital and Washington University Medical Center in St. Louis, Missouri. She is also Adjunct Clinical Instructor for the Barnes-Jewish Hospital Goldfarb School of Nursing and St. Louis College of Pharmacy. Dr. Wolfe is responsible for the provision of clinical pharmacy services in the perioperative and periprocedural environment and for the coordination of clinical services provided by four operating room pharmacy satellites. She also serves as a preceptor for Doctor of Pharmacy students and pharmacy residents and is co-chair of the Enhanced Surgical Recovery Pharmacy & Documentation committee and the Analgesia subcommittee of the Pharmacy & Therapeutics committee. Dr. Wolfe earned her Doctor of Pharmacy degree from St. Louis College of Pharmacy and Master of Health Administration degree from Webster University, also in St. Louis. She completed her residency training at University of Kentucky HealthCare, and she is board certified in critical care. Dr. Wolfe is a member of the American College of Clinical Pharmacy, American Society of Enhanced Recovery, and Society of Critical Care Medicine. In 2011 she received Barnes-Jewish Hospital’s David A. Gee Meritorious Service Award and Team Award for Quality Improvement for Anesthesia Medication Management.
J. Ross Renew, MD, FASA, FASE
Vice Chair for Research, Department of Anesthesiology and Perioperative Medicine
Associate Professor of Anesthesiology
Mayo Clinic
Jacksonville, Florida
Dr. Renew is currently an Associate Professor of Anesthesiology and serves as the Vice Chair of Research for his department at the Mayo Clinic in Jacksonville, Florida. Dr. Renew completed his anesthesiology residency at Mayo Clinic in Jacksonville, Florida and his Adult Cardiothoracic Anesthesiology at Mayo Clinic in Rochester, Minnesota. Dr. Renew is an active researcher and leads a team interested in neuromuscular blockade, neuromuscular blockade monitoring, and practical strategies to optimize neuromuscular blockade management. In addition to his research efforts, he serves as the Associate Residency Director and is passionate about educating the next generation of anesthesiologists on the best way to manage neuromuscular blockade.
Jeffery S. Vender, MD, MCCM, MBA is the Emeritus, Harris Family Foundation Chairman of the Department of Anesthesiology at NorthShore University Health System in Evanston, Illinois and a Clinical Professor at the University of Chicago Pritzker School Of Medicine in Chicago, Illinois. He is a past member of the NorthShore University Health System Faculty Practice Associates Board of Directors, Past Chair of the Medical Executive Committee for the Professional Staff at NorthShore and previously served on Northshore’s Board of Directors. Dr. Vender served as Chair of Anesthesia from 1990-2015 and received an appointment of adjunct Professor of Biomedical Engineering at Northwestern University. He served as the Director of the Critical Care Services at Evanston Hospital from 1987-2000 and the Interim Chairman at Northwestern University Department of Anesthesiology from July 1999 until October 2000. Dr. Vender has participated and Chaired numerous state and national committees of various medical organizations, edited several medical texts, has published over 135 articles and book chapters and has been an invited lecturer at over 250 national and international meetings on topics of anesthesiology, critical care, organizational change, and leadership. In addition, Dr. Vender serves as an editor and/or reviewer for many medical journals.
Relevant Financial Relationship Disclosures
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
- Rachel C. Wolfe: Heron Therapeutics – Speaker’s bureau, Merck – Advisor
- J. Ross Renew: Merck – Principle Investigator for Research Grant
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
Methods and CE Requirements
Claim CE Within 60 Days
To receive CE credit, complete the steps below within 60 days of completing the activity.
- View the entire presentation and answer all polling questions.
- Click "Complete Activity" on last slide then complete the evaluation to claim credit.
- Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.
Important Note – ACPE 60 Day Deadline
Provided by ASHP
Supported by an educational grant from Merck.